ARKG
- ARK Genomic Revolution ETF关键资讯
| 最早日期 | 2014-10-31 |
ETF 资讯
| 基金提供者 | ARK Invest |
| 指数 | Active (No Index) |
| 费用率 | 0.75% |
| 持仓数量 | 42 |
| 成立日期 | 2014-10-31 |
| 资产类别 | Equity |
| 上市地 | US-listed |
| 产业 | Healthcare |
| 投资风格 | Growth |
| 非杠杆型 | Non-leveraged |
关于 ARKG
The ARK Genomic Revolution ETF is an actively managed fund that invests in companies driving advancements in genomics, gene editing, genetic therapy, molecular diagnostics, and stem cell advances. The fund's portfolio is tilted towards smaller firms and is designed to capture long-term growth potential in the healthcare and biotechnology sectors.